BPIQ Blog

Jan 4, 20235 min read

How does Lecanemab compare to other Alzheimer's assets?

Summary: Biogen and Eisai's asset Lecanemab has a PDUFA date set for Friday 1/6/23 Lecanemab targets and effectively reduces beta-amyloid...

Jul 25, 20224 min read

(Originally posted 7/25/2022, updated 7/27/22) Summary BPIQ monitors mergers and acquisitions (M&A's) of smid-cap biopharmas Acquisition...

Our platform helps you uncover your next biotech investment opportunity